DD296841A5 - Intravenoese loesungen mit schnellem wirkungseintritt - Google Patents
Intravenoese loesungen mit schnellem wirkungseintritt Download PDFInfo
- Publication number
- DD296841A5 DD296841A5 DD90341215A DD34121590A DD296841A5 DD 296841 A5 DD296841 A5 DD 296841A5 DD 90341215 A DD90341215 A DD 90341215A DD 34121590 A DD34121590 A DD 34121590A DD 296841 A5 DD296841 A5 DD 296841A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- carbamazepine
- cyclodextrin
- solution
- water
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH208489 | 1989-06-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD296841A5 true DD296841A5 (de) | 1991-12-19 |
Family
ID=4225529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD90341215A DD296841A5 (de) | 1989-06-02 | 1990-05-31 | Intravenoese loesungen mit schnellem wirkungseintritt |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0400609A1 (no) |
| JP (1) | JPH0320224A (no) |
| KR (1) | KR910000161A (no) |
| AU (1) | AU5594190A (no) |
| CA (1) | CA2017959A1 (no) |
| DD (1) | DD296841A5 (no) |
| FI (1) | FI902655A0 (no) |
| HU (1) | HUT57588A (no) |
| IL (1) | IL94514A0 (no) |
| NO (1) | NO902450L (no) |
| PT (1) | PT94219A (no) |
| ZA (1) | ZA904206B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5466683A (en) * | 1994-08-25 | 1995-11-14 | Teva Pharmaceutical Industries Ltd. | Water-soluble analogs of carbamazepine |
| EP1304127B1 (en) | 2000-03-01 | 2007-08-22 | Kao Corporation | Dissipating method for volatile components |
| KR20010100420A (ko) * | 2000-05-02 | 2001-11-14 | 이홍섭 | 필름 형태의 연마재를 갖는 초정밀 연마기에서 순차제어를이용한 자동화 방법 및 그 장치 |
| WO2007084541A2 (en) * | 2006-01-17 | 2007-07-26 | Regents Of The University Of Colorado | Central administration of stable formulations of therapeutic agents for cns conditions |
| AU2008279636A1 (en) * | 2007-07-25 | 2009-01-29 | The Regents Of The University Of Colorado | Central administration of stable formulations of therapeutic agents for CNS conditions |
| CN105726466A (zh) * | 2014-12-10 | 2016-07-06 | 辽宁药联制药有限公司 | 一种奥卡西平注射剂及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| GB8506792D0 (en) * | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
-
1990
- 1990-05-25 AU AU55941/90A patent/AU5594190A/en not_active Abandoned
- 1990-05-25 IL IL94514A patent/IL94514A0/xx unknown
- 1990-05-28 FI FI902655A patent/FI902655A0/fi not_active Application Discontinuation
- 1990-05-30 EP EP90110267A patent/EP0400609A1/de not_active Withdrawn
- 1990-05-31 DD DD90341215A patent/DD296841A5/de not_active IP Right Cessation
- 1990-05-31 CA CA002017959A patent/CA2017959A1/en not_active Abandoned
- 1990-05-31 PT PT94219A patent/PT94219A/pt not_active Application Discontinuation
- 1990-05-31 KR KR1019900007930A patent/KR910000161A/ko not_active Application Discontinuation
- 1990-06-01 JP JP2141764A patent/JPH0320224A/ja active Pending
- 1990-06-01 NO NO90902450A patent/NO902450L/no unknown
- 1990-06-01 HU HU903303A patent/HUT57588A/hu unknown
- 1990-06-01 ZA ZA904206A patent/ZA904206B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI902655A0 (fi) | 1990-05-28 |
| JPH0320224A (ja) | 1991-01-29 |
| NO902450L (no) | 1990-12-03 |
| PT94219A (pt) | 1991-02-08 |
| EP0400609A1 (de) | 1990-12-05 |
| CA2017959A1 (en) | 1990-12-02 |
| AU5594190A (en) | 1990-12-06 |
| NO902450D0 (no) | 1990-06-01 |
| HU903303D0 (en) | 1990-10-28 |
| KR910000161A (ko) | 1991-01-29 |
| HUT57588A (en) | 1991-12-30 |
| ZA904206B (en) | 1991-02-27 |
| IL94514A0 (en) | 1991-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69734742T2 (de) | Arzneizusammensetzungen enthaltend Ascomycinderivate | |
| DE69727218T2 (de) | Einschlusskomplexe von aryl-heterozyklischen salzen | |
| DE69109021T2 (de) | Augentropfenarzneimittel. | |
| DE602005001833T2 (de) | Zusammensetzungen enthaltend Ecteinascidin und einen Disaccharide | |
| DE3346123A1 (de) | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung | |
| DE60011149T2 (de) | Klare wässrige anästhesierende zusammensetzung | |
| EP0684839B1 (de) | Verfahren zur herstellung kolloidaler wässriger lösungen schwer löslicher wirkstoffe | |
| DE69518070T2 (de) | Mehrfachkomponenten-inklusionskomplexe enthaltend einen sauren arzneistoff, ein zyklodextrin und eine base | |
| DE60305438T2 (de) | Lyophilisierte pharmazeutische zusammensetzung von propofol | |
| DE69730902T2 (de) | Verfahren zur Selektion eines Salzes zur Herstellung eines Inklusionskomplexes | |
| EP0435826A1 (de) | Intravenöse Lösungen für Status Epilepticus | |
| DE69625200T2 (de) | Arzneimittel enthaltend lamotrigin | |
| DE10228049A1 (de) | Flüssige Zubereitung enthaltend Oligopeptide | |
| EP1787641A1 (de) | Tazobactam-Piperacillin-Lyophilisat | |
| EP0705601B1 (de) | Lösungen von Anthrachinonen zur parenteralen Applikation | |
| DE69904727T2 (de) | Injizierbares arzneimittel auf basis eines pharmazeutisch verträglichen salzes von clopidogrel bzw. von ticlopidin | |
| DE60305813T2 (de) | Stabile Oxazaphosphorin-2-Mercaptoethansulphonat Formulierungen | |
| EP0277462B1 (de) | Verfahren zur Herstellung nasaler Lösungen enthaltend synthetisches Human calcitonin. | |
| DD296841A5 (de) | Intravenoese loesungen mit schnellem wirkungseintritt | |
| AT397460B (de) | Verfahren zur herstellung eines pharmazeutischen trockenpräparates enthaltend ein diclofenac-salz | |
| DE69130832T2 (de) | Injizierbare amphotericin b enthaltende dispersion | |
| DE69006259T2 (de) | Hypoallergene anästhesierende/hypnotische steroide Arzneizubereitung. | |
| CH647677A5 (de) | 4'-(acridinylamino)-methansulfon-anisidid enthaltende pharmazeutische zusammensetzung. | |
| DE3782480T2 (de) | Gefriergetrocknete arzneimittel mit phenylchinolincarbonsaeuren. | |
| DE60101979T2 (de) | Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |